OPKO Health, Inc. Area of Real Estate Property
OPKO Health, Inc. (OPK) had Area of Real Estate Property of 29.50 thousand sqft as of 2019-08-01, per its 10-Q filed 2024-08-07.
Discontinued › Notes › Consolidation and Presentation of Financial Statements
us-gaap:AreaOfRealEstateProperty · last filed 2024-08-07
- 2019-08-01: Area of Real Estate Property 29.50K sqft.
| Period end | Area of Real Estate Property |
|---|---|
| 2019-08-01 | 29.50K sqft 10-Q · filed 2024-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |